Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
Gastroesophageal reflux disease (GERD) is a chronic, progressive, and costly medical condition affecting a substantial proportion of the world population, predominantly the Western population. The available treatment options for patients with refractory GERD symptoms are limited to either laparoscop...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Gastrointestinal Endoscopy
2016-03-01
|
Series: | Clinical Endoscopy |
Subjects: | |
Online Access: | http://www.e-ce.org/upload/pdf/ce-2015-044.pdf |
_version_ | 1797642534133956608 |
---|---|
author | Deepanshu Jain Shashideep Singhal |
author_facet | Deepanshu Jain Shashideep Singhal |
author_sort | Deepanshu Jain |
collection | DOAJ |
description | Gastroesophageal reflux disease (GERD) is a chronic, progressive, and costly medical condition affecting a substantial proportion of the world population, predominantly the Western population. The available treatment options for patients with refractory GERD symptoms are limited to either laparoscopic surgery with significant sequelae or potentially lifelong, high-dose proton pump inhibitor therapy. The restoration of the antireflux competence of the gastroesophageal junction at the anatomic and physiologic levels is critical for the effective long-term treatment of GERD. Transoral incisionless fundoplication (TIF) surgery is a safe, well-tolerated, and effective treatment that has yielded significant symptomatic improvement in patients with medically refractory GERD symptoms. In this review article, we have summarized case series and reports describing the role of TIF for patients with gastroesophageal reflux symptoms. The reported indications, techniques, complications, and success rates are also discussed. |
first_indexed | 2024-03-11T14:01:39Z |
format | Article |
id | doaj.art-c947c289f39e4cf39299fc4692dbb446 |
institution | Directory Open Access Journal |
issn | 2234-2400 2234-2443 |
language | English |
last_indexed | 2024-03-11T14:01:39Z |
publishDate | 2016-03-01 |
publisher | Korean Society of Gastrointestinal Endoscopy |
record_format | Article |
series | Clinical Endoscopy |
spelling | doaj.art-c947c289f39e4cf39299fc4692dbb4462023-11-02T04:14:50ZengKorean Society of Gastrointestinal EndoscopyClinical Endoscopy2234-24002234-24432016-03-0149214715610.5946/ce.2015.0446834Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?Deepanshu Jain0Shashideep Singhal1 Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA Division of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center at Houston, Houston, TX, USAGastroesophageal reflux disease (GERD) is a chronic, progressive, and costly medical condition affecting a substantial proportion of the world population, predominantly the Western population. The available treatment options for patients with refractory GERD symptoms are limited to either laparoscopic surgery with significant sequelae or potentially lifelong, high-dose proton pump inhibitor therapy. The restoration of the antireflux competence of the gastroesophageal junction at the anatomic and physiologic levels is critical for the effective long-term treatment of GERD. Transoral incisionless fundoplication (TIF) surgery is a safe, well-tolerated, and effective treatment that has yielded significant symptomatic improvement in patients with medically refractory GERD symptoms. In this review article, we have summarized case series and reports describing the role of TIF for patients with gastroesophageal reflux symptoms. The reported indications, techniques, complications, and success rates are also discussed.http://www.e-ce.org/upload/pdf/ce-2015-044.pdfEndoscopic fundoplicationGastroesophageal refluxProton pump inhibitors |
spellingShingle | Deepanshu Jain Shashideep Singhal Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? Clinical Endoscopy Endoscopic fundoplication Gastroesophageal reflux Proton pump inhibitors |
title | Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? |
title_full | Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? |
title_fullStr | Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? |
title_full_unstemmed | Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? |
title_short | Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand? |
title_sort | transoral incisionless fundoplication for refractory gastroesophageal reflux disease where do we stand |
topic | Endoscopic fundoplication Gastroesophageal reflux Proton pump inhibitors |
url | http://www.e-ce.org/upload/pdf/ce-2015-044.pdf |
work_keys_str_mv | AT deepanshujain transoralincisionlessfundoplicationforrefractorygastroesophagealrefluxdiseasewheredowestand AT shashideepsinghal transoralincisionlessfundoplicationforrefractorygastroesophagealrefluxdiseasewheredowestand |